Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Protokinetix Inc (PKTX)

Protokinetix Inc (PKTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0910 +21.76%
on 01/02/20
0.1300 -14.77%
on 01/15/20
+0.0108 (+10.80%)
since 12/17/19
3-Month
0.0820 +35.12%
on 11/01/19
0.1400 -20.86%
on 11/21/19
+0.0107 (+10.69%)
since 10/17/19
52-Week
0.0500 +121.60%
on 02/22/19
0.3200 -65.38%
on 06/10/19
+0.0388 (+53.89%)
since 01/17/19

Most Recent Stories

More News
ProtoKinetix AAGP(R) Dry Eye Therapy Testing Results

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) announces that ITR Laboratories of Montreal have run multiple tests on eye irritation at maximum concentration...

PKTX : 0.1108 (+0.73%)
ProtoKinetix AAGP(R) Retinal Cell Replacement Therapy Testing at UBC Completed

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) announces the completion of an in vivo study to assess the effect of AAGP(R) on the long term survival and...

PKTX : 0.1108 (+0.73%)
ProtoKinetix AAGP(R) Dry Eye Therapy Program Launched

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) announces the initiation of a program testing AAGP(R), to develop a potential therapy to treat Dry Eye Disease...

PKTX : 0.1108 (+0.73%)
ProtoKinetix AAGP(R) Operational Update

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) is pleased to provide the following updates regarding upcoming news in key areas.

PKTX : 0.1108 (+0.73%)
Tests Show AAGP(R) Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month Milestone

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) updates shareholders regarding ongoing 3rd stage testing of retinal cell replacement therapy at the University...

PKTX : 0.1108 (+0.73%)
ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) has reached the mid-point of 3rd stage of testing in retinal cell replacement therapy at the University...

PKTX : 0.1108 (+0.73%)
ProtoKinetix Achieves Primary Objective Safety at Midpoint of Clinical Trial

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) today announced reaching the midpoint of a Phase-1 first-in-human clinical trial of...

PKTX : 0.1108 (+0.73%)
ProtoKinetix First in Series of Town Hall Shareholder Meetings

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) today announces that it will hold the first in a series of Town Hall Meetings. This...

PKTX : 0.1108 (+0.73%)
Agreement Secured by ProtoKinetix to Start Heart Research Product Validation Studies

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) is announcing that the Company has secured a partnership agreement with IMPART investigator...

PKTX : 0.1108 (+0.73%)
ProtoKinetix Discusses Investor Awareness Campaign and Recent Market Activity

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX) has been requested by OTC Markets Group to comment on certain recent promotional activity...

OTCM : 34.5000 (+0.79%)
PKTX : 0.1108 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PKTX with:

Key Turning Points

2nd Resistance Point 0.1108
1st Resistance Point 0.1108
Last Price 0.1108
1st Support Level 0.1108
2nd Support Level 0.1108

See More

52-Week High 0.3200
Fibonacci 61.8% 0.2169
Fibonacci 50% 0.1850
Fibonacci 38.2% 0.1531
Last Price 0.1108
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar